| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Aug 2025 | 29 Jul 2025 |
| Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve the un-audited financial results for the quarter ended on 30-06-2025; finalize the date venue of 32nd A.G.M. along with the Notice of AGM. Approved the un-audited financial results for the 1st quarter ended June 30, 2025. Please find attached approved un-audited financial results for the 1st quarter ended on 30/06/2025. (As Per BSE Announcement Dated on :06.08.2025) | ||
| Board Meeting | 2 Jun 2025 | 2 Jun 2025 |
| Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, 2nd June, 2025, has, based on the recommendation of the Nomination and Remuneration Committee appointed Ms. Vandana Gupta a qualified Company Secretary as the Company Secretary and Compliance Officer designated as Key Managerial Person of the Company with effect from 2nd June, 2025. | ||
| Board Meeting | 28 May 2025 | 28 May 2025 |
| Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, 28th May, 2025 has: - 1. Based on the recommendation of the Nomination and Remuneration Committee appointed Ms. Kiran Satyawan Vaidya as the Chief Financial Officer (CFO) Key Managerial Person of the Company with effect from 28th May 2025. In this regard, please find attached the particulars of the disclosure required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Part A of Schedule III and SEBI Master Circular dated November 11, 2024 as Annexure A. | ||
| Board Meeting | 10 May 2025 | 30 Apr 2025 |
| Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2025. Approved the Audited Financial Results for the quarter and year ended March 31, 2025 along with unmodified auditors report issued by statutory auditor. (As Per BSE Announcement Dated on :10.05.2025) | ||
| Board Meeting | 13 Mar 2025 | 13 Mar 2025 |
| The Board of Director of the Company, today i.e, 13.03.2025, considered and approved the allotment of 2,00,000 10% Cumulative Non-Convertible Redeemable Preference Share of Rs. 50/- each | ||
| Board Meeting | 6 Mar 2025 | 6 Mar 2025 |
| The board of director of the Company today, consider and approve the allotment of 240000 shares, 10%, Cumulative, Non-convertible, redeemable preference shares @ Rs. 50/- each on private placement. The Board of Directors of the Company, today i.e., considered and approved the allotment of 2,40,000 (Two Lakh Forty Thousand)10% Cumulative Non-Convertible Redeemable Preference Shares of Rs. 50/- (Rupees Fifty Only) each at par in cash on private placement basis to the following allottees by passing board resolution at the Board Meeting held today i.e. 06/03/2025 at Regd. Office 6A, Kiran Sankar Roy Road, 3rd Floor, Kolkata- 700 001 West Bengal, India. | ||
| Board Meeting | 27 Feb 2025 | 27 Feb 2025 |
| Please find attached the intimation for allotment of preference shares. | ||
| Board Meeting | 14 Feb 2025 | 8 Feb 2025 |
| SHENTRACON CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve Regulation 29 Of LODR Regarding Declaration Of Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2024. This is to inform that the Board of Director of the Company at their meeting held today 14.02.2025 inter-alia, consider and approved the un-audited financial results for the quart ended 31-12-2024. The Board authorised Mr. Sanjay Sureka, Director of the Company to sign the results on behalf of the Company. (As Per BSE Announcement Dated on 14.02.2025) | ||
| Board Meeting | 27 Dec 2024 | 23 Dec 2024 |
| SHENTRACON CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/12/2024 inter alia to consider and approve 1) Variation of preference shareholder rights by conversion rights and pre- mature redemption; 2) Reclassification of authorized share capital of the company and consequential amendment in the capital clause of memorandum of association of the company; 3) Issue of redeemable non-convertible preference shares for the purpose of redemption of the existing preference shares; 4) Approval of Notice of Meeting of Preference Share Holders through Postal Ballot. 5) Approval of Notice of Equity Share Holder through Postal Ballot 6) Approval of Notice of Extra-Ordinary General Meeting of equity shareholders physically at the registered office of the Company at 6A Kiran Sankar Roy Road 3rd Floor Kolkata 700001. 7) Delisting of company from the Calcutta Stock Exchange Limited. Please find attached Outcome of Board Meeting held today 27/12/2024 under Reg. 30 of SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 27/12/2024) | ||
| Board Meeting | 12 Nov 2024 | 5 Nov 2024 |
| SHENTRACON CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve In term of regulation 29 of SEBI (LODR) Regulations 2015 the meeting of Board of Directors of the Company is scheduled to be held on Tuesday 12th November 2024 at 15:00 hour to approve the un-audited financial results for the quarter ended 30-09-2024. This is to inform that the Board of Directors of the Company at their meeting held today 12-11-2024, inter-alia, consider and approved the un-audited financial results for the quarter and half year ended 30-09-2024 (As per BSE Announcement Dated on 12/11/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.